bioAffinity Technologies Inc. (BIAF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

bioAffinity Technologies ...

NASDAQ: BIAF · Real-Time Price · USD
2.61
-0.17 (-6.12%)
At close: Oct 03, 2025, 3:59 PM
2.62
0.38%
After-hours: Oct 03, 2025, 06:15 PM EDT

bioAffinity Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.36M 2.53M 4.8K n/a
Cost of Revenue
5.98M 1.74M 467.00 4.82K
Gross Profit
3.38M 791.62K 4.34K -4.82K
Operating Income
-8.95M -7.97M -4.01M -2.21M
Interest Income
17.61K 122.13K 46.71K 424.00
Pretax Income
-9.03M -7.92M -8.15M -6.32M
Net Income
-9.04M -7.94M -8.15M -6.33M
Selling & General & Admin
9.94M 6.79M 2.73M 880.77K
Research & Development
1.78M 1.73M 1.29M 1.33M
Other Expenses
606K 249.59K 10.18K n/a
Operating Expenses
12.33M 8.77M 4.01M 2.21M
Interest Expense
92.47K 37.13K 2.53M 1M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
18.32M 10.51M 4.02M 2.21M
Income Tax Expense
11.65K 20.99K 2.46K 1.95K
Shares Outstanding (Basic)
404.33K 291.6K 149.97K 245.93K
Shares Outstanding (Diluted)
404.33K 291.6K 149.97K 245.93K
EPS (Basic)
-22.5 -27.3 -54.3 -25.8
EPS (Diluted)
-22.5 -27.3 -54.3 -25.8
EBITDA
-8.33M -7.63M -5.61M -2.2M
EBIT
-8.94M -7.88M -5.62M -2.21M
Depreciation & Amortization
605.64K 249.59K 10.18K 4.82K